Stock Performance Overview
The stock has experienced a sustained decline over recent weeks, with a consecutive six-day losing streak resulting in an 8.51% drop in returns during this period. On 26 Feb 2026, the share price fell by 2.44%, underperforming the Sensex which declined by 0.18% on the same day. This underperformance extends across multiple time frames: a 1-week loss of 8.44% versus the Sensex’s 0.45% decline, a 1-month drop of 10.23% compared to the Sensex’s 0.72% gain, and a 3-month fall of 24.22% against the Sensex’s 4.07% decrease.
Year-to-date, the stock has declined by 17.92%, significantly lagging the Sensex’s 3.63% fall. Over the past year, Medi Assist Healthcare Services Ltd has posted a negative return of 19.89%, contrasting sharply with the Sensex’s positive 10.09% gain. The stock’s three- and five-year returns remain at 0.00%, while the Sensex has appreciated by 38.11% and 67.26% respectively over the same periods. Over a decade, the stock has not recorded any gains, whereas the Sensex surged by 254.69%.
Technical Indicators and Market Position
Technically, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish trend. The share price is also underperforming its sector by 1.58% on the day of reporting, reflecting broader sector pressures within the insurance industry.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Financial Metrics and Profitability
The company reported a Profit Before Tax (PBT) excluding other income of ₹15.11 crores in the latest quarter, reflecting a decline of 23.9% compared to the average of the previous four quarters. Net Profit After Tax (PAT) for the quarter stood at ₹11.11 crores, down 45.4% from the preceding four-quarter average. Interest expenses reached a quarterly high of ₹8.39 crores, indicating increased financial costs.
Despite these declines in quarterly profitability, the company maintains a Return on Equity (ROE) of 14.05%, which is considered strong within its sector. However, the stock’s valuation remains elevated with a Price to Book (P/B) ratio of 5, suggesting that the market prices the company at a premium relative to its book value. This valuation is notably expensive when compared to its peers’ historical averages, even as the stock trades at a discount relative to those peers currently.
Relative Market Performance and Ratings
Medi Assist Healthcare Services Ltd has consistently underperformed the benchmark indices over the last three years. The stock has failed to generate positive returns over this period, contrasting with the broader market’s gains. It has also underperformed the BSE500 index in each of the last three annual periods, underscoring persistent challenges in delivering shareholder value.
Reflecting these trends, the company’s Mojo Score stands at 21.0, with a Mojo Grade of Strong Sell as of 2 Dec 2025, an upgrade from the previous Sell rating. The Market Cap Grade is rated at 3, indicating a moderate market capitalisation relative to other listed companies in the sector.
Sector and Industry Context
Operating within the insurance sector, Medi Assist Healthcare Services Ltd faces a competitive environment where valuation and profitability metrics are closely scrutinised. The company’s recent performance contrasts with the broader sector trends, where some peers have managed to sustain or improve profitability and market valuations.
Holding Medi Assist Healthcare Services Ltd from Insurance? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Current Situation
Medi Assist Healthcare Services Ltd’s stock has reached a historic low point, reflecting a combination of declining quarterly profits, elevated interest expenses, and a valuation that remains high despite recent price falls. The stock’s performance has lagged significantly behind benchmark indices and sector averages over multiple time horizons, including the short, medium, and long term.
While the company maintains a solid ROE, the recent financial results and market performance indicate a challenging environment for the stock. The downgrade to a Strong Sell rating by MarketsMOJO further emphasises the cautious stance on the stock’s near-term outlook based on current data.
Investors and market participants will note the stock’s position relative to its moving averages and sector peers, as well as the ongoing downward trend in share price and returns. The company’s financial metrics and market capitalisation grade provide additional context for understanding its current standing within the insurance sector.
Long-Term Fundamental Strength
Despite recent setbacks, Medi Assist Healthcare Services Ltd exhibits strong long-term fundamental strength, as evidenced by its average ROE of 14.05%. This metric suggests that the company has maintained a degree of profitability and capital efficiency over time, even as recent quarters have shown declines in earnings and increased financial costs.
Valuation Considerations
The stock’s Price to Book ratio of 5 indicates a valuation premium that may reflect investor expectations of future growth or sector positioning. However, this premium exists alongside a share price that has fallen sharply, suggesting a complex valuation dynamic that balances historical performance, current earnings pressures, and market sentiment.
Conclusion
Medi Assist Healthcare Services Ltd’s fall to an all-time low is a significant market event, highlighting the stock’s ongoing challenges in delivering returns and maintaining profitability relative to its sector and benchmark indices. The combination of declining quarterly profits, elevated interest expenses, and a high valuation multiple contribute to the stock’s current status and rating.
Market participants will continue to monitor the company’s financial disclosures and market performance for further developments, with the current data underscoring a period of notable underperformance and valuation complexity.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
